BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jiang Y, Zhao L, Chen Q, Zhou L. Exploring the Mechanism of Berberine Intervention in Ulcerative Colitis from the Perspective of Inflammation and Immunity Based on Systemic Pharmacology. Evid Based Complement Alternat Med 2021;2021:9970240. [PMID: 34211579 DOI: 10.1155/2021/9970240] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Yang Y, Qian C, Wu R, Wang R, Ou J, Liu S. Exploring the mechanism of the Fructus Mume and Rhizoma Coptidis herb pair intervention in Ulcerative Colitis from the perspective of inflammation and immunity based on systemic pharmacology. BMC Complement Med Ther 2023;23:11. [PMID: 36647064 DOI: 10.1186/s12906-022-03823-7] [Reference Citation Analysis]
2 Fang S, Gao Y, Fang Y, Sun J, Xie Z. Mechanism Underlying the Action of Berberine in the Treatment of Gouty Arthritis Based on Network Pharmacology. Natural Product Communications 2023;18:1934578X2211436. [DOI: 10.1177/1934578x221143627] [Reference Citation Analysis]
3 Zecheng Luo, Zihao Li, Zheng Liang, Lin Wang, Guanlin He, Dongdi Wang, Lei Shen, Zhengting Wang, Xiuying Ma, Funeng Geng, Haozhong Wang, Wenping Liu, Huijuan Liu, Baojie Li. Berberine increases stromal production of Wnt molecules and activates Lgr5+ stem cells to promote epithelial restitution in experimental colitis. BMC Biol 2022;20:287. [PMID: 36528592 DOI: 10.1186/s12915-022-01492-z] [Reference Citation Analysis]
4 Yu H, Zhang F, Wen Y, Zheng Z, Chen G, Pan Y, Wu P, Ye Q, Han J, Chen X, Liu C, Shen T. Mechanism of interventional effect and targets of Zhuyu pill in regulating and suppressing colitis and cholestasis. Front Pharmacol 2022;13:1038188. [PMID: 36408242 DOI: 10.3389/fphar.2022.1038188] [Reference Citation Analysis]
5 Hu S, Wei P, Li W, Liu Q, Chen S, Hu C, Guo X, Ma X, Zeng J, Zhang Y. Pharmacological effects of berberine on models of ulcerative colitis: A meta-analysis and systematic review of animal studies. Front Pharmacol 2022;13:937029. [DOI: 10.3389/fphar.2022.937029] [Reference Citation Analysis]
6 He L, Zhong Z, Chen M, Liang Q, Wang Y, Tan W. Current Advances in Coptidis Rhizoma for Gastrointestinal and Other Cancers. Front Pharmacol 2022;12:775084. [DOI: 10.3389/fphar.2021.775084] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Chang JM, Wu JY, Chen SH, Chao WY, Chuang HH, Kam KH, Zhao PW, Li YZ, Yen YP, Lee YR. 9-O-Terpenyl-Substituted Berberrubine Derivatives Suppress Tumor Migration and Increase Anti-Human Non-Small-Cell Lung Cancer Activity. Int J Mol Sci 2021;22:9864. [PMID: 34576028 DOI: 10.3390/ijms22189864] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]